Anemia of inflammation: the hepcidin link

被引:141
作者
Roy, CN
Andrews, NC
机构
[1] Childrens Hosp, Karp Family Res Labs, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
anemia; hemochromatosis; hepcidin; inflammation; iron recycling;
D O I
10.1097/00062752-200503000-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review The anemia of inflammation has been associated for nearly two decades with elevated cytokine levels, but the primary mediator of this condition was unknown. Recently hepcidin antimicrobial peptide has emerged as the hormone that links the type 11 acute phase response to iron handling and erythropoiesis. Recent findings Hepcidin antimicrobial peptide likely modulates iron transport from macrophages and enterocytes to red blood cell precursors as a consequence of its interaction with SLC40A1/ferroportin, the only known transporter that facilitates iron egress. Insights into the regulation of hepcidin antimicrobial peptide expression by known iron metabolic proteins such as HFE, hemojuvelin, and transferrin receptor 2 are expanding the understanding of the genetic circuitry that controls iron absorption and utilization. Summary Increasingly, experiments suggest the hepatocyte is not just the iron storage depot but is the 'command central' for the maintenance of iron homeostasis. It receives multiple signals related to iron balance and responds via transcriptional control of hepcidin antimicrobial peptide.
引用
收藏
页码:107 / 111
页数:5
相关论文
共 36 条
  • [1] Decreased hepcidin mRNA expression in thalassemic mice
    Adamsky, K
    Weizer, O
    Amariglio, N
    Breda, L
    Harmelin, A
    Rivella, S
    Rachmilewitz, E
    Rechavi, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (01) : 123 - 124
  • [2] Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis
    Bridle, KR
    Frazer, DM
    Wilkins, SJ
    Dixon, JL
    Purdie, DM
    Crawford, DHG
    Subramaniam, VN
    Powell, LW
    Anderson, GJ
    Ramm, GA
    [J]. LANCET, 2003, 361 (9358) : 669 - 673
  • [3] CARTWRIGHT G. E., 1966, SEMINARS HEMATOL, V3, P351
  • [4] A homozygous HAMP mutation in a multiply consanguineous family with pseudo-dominant juvenile hemochromatosis
    Delatycki, MB
    Allen, KJ
    Gow, P
    MacFarlane, J
    Radomski, C
    Thompson, J
    Hayden, MR
    Goldberg, YP
    Samuels, ME
    [J]. CLINICAL GENETICS, 2004, 65 (05) : 378 - 383
  • [5] FINCH C, 1994, BLOOD, V84, P1697
  • [6] Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
    Ganz, T
    [J]. BLOOD, 2003, 102 (03) : 783 - 788
  • [7] Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron
    Gehrke, SG
    Kulaksiz, H
    Herrmann, T
    Riedel, HD
    Bents, K
    Veltkamp, C
    Stremmel, W
    [J]. BLOOD, 2003, 102 (01) : 371 - 376
  • [8] RADIOACTIVE IRON ABSORPTION BY GASTRO-INTESTINAL TRACT
    Hahn, P. F.
    Bale, W. F.
    Ross, J. F.
    Balfour, W. M.
    Whipple, G. H.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1943, 78 (03) : 169 - 188
  • [9] HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype
    Jacolot, S
    Le Gac, G
    Scotet, V
    Quere, I
    Mura, C
    Ferec, C
    [J]. BLOOD, 2004, 103 (07) : 2835 - 2840
  • [10] Molecular cloning of transferrin receptor 2 - A new member of the transferrin receptor-like family
    Kawabata, H
    Yang, S
    Hirama, T
    Vuong, PT
    Kawano, S
    Gombart, AF
    Koeffler, HP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (30) : 20826 - 20832